Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Upper gastrointestinal Crohn's disease.

Christian Mottet1, Pascal Juillerat, Valérie Pittet

  • 1Division of Gastroenterology and Hepatology, Centre Hospitalier Universitaire Vaudois and University of Lausanne, Lausanne, Switzerland. christian.mottet@chuv.ch

Digestion
|February 2, 2008
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Spatial mapping of human colonic niches reveals rapid, mucus-specific microbiota disruption after bowel cleansing.

Gut microbes·2026
Same author

Efficacy and Safety with Upadacitinib by Baseline Corticosteroid Use in Patients with Moderately to Severely Active Crohn's Disease.

Inflammatory bowel diseases·2025
Same author

Diagnosis and management of patients with Crohn's disease. Position paper from the GETAID.

Clinics and research in hepatology and gastroenterology·2025
Same author

International Survey of Gastroenterologists on Managing Inflammatory Bowel Disease During Pregnancy and Lactation: Current State and the Necessity for Improvements.

United European gastroenterology journal·2025
Same author

Risk-based guidance for choosing fecal immunochemical test or colonoscopy in colorectal cancer screening: a modeling study.

American journal of epidemiology·2025
Same author

Development of a Deprescribing Intervention for Proton Pump Inhibitors in Primary Care: A Co-Design Approach With General Practitioners and Patients.

Basic & clinical pharmacology & toxicology·2025
Same journal

Directional Bias in Polyp Detection during Colonoscopy: A Prospective Observational Study.

Digestion·2026
Same journal

Prospective validation of magnified endoscopic examination with image-enhanced endoscopy as an optical biopsy for differentiating superficial duodenal epithelial tumor and non-neoplastic lesion in duodenum.

Digestion·2026
Same journal

Accurate imaging diagnosis of small pancreatic carcinoma/high-grade pancreatic intraepithelial neoplasia using combined indirect imaging findings.

Digestion·2026
Same journal

Restoration of gut microbiota dysbiosis by a probiotic Lactobacillus paragasseri OLL2716 in patients being treated with low-dose aspirin and acid-suppressive agents.

Digestion·2026
Same journal

Adverse Events after Colorectal Polypectomy in Patients with Amyloidosis: Risk Assessment Using Propensity Score Matching.

Digestion·2026
Same journal

Prognostic effect of MES 1 inflammatory extent on remission maintenance in ulcerative colitis.

Digestion·2026
See all related articles

Symptomatic gastroduodenal Crohn's disease is uncommon, but may be found in up to 40% of patients. Treatment typically mirrors distal disease management, with surgery or dilation for obstructive symptoms.

Area of Science:

  • Gastroenterology
  • Internal Medicine

Background:

  • Symptomatic gastroduodenal Crohn's disease (CD) is rare, affecting less than 4% of patients.
  • Gastroduodenal involvement in CD is often asymptomatic, detected endoscopically (20%) or histologically (up to 40%).
  • Histological findings commonly include Helicobacter pylori-negative focal gastritis, frequently associated with distal ileal disease.

Purpose of the Study:

  • To review the presentation and management of gastroduodenal manifestations in Crohn's disease.

Main Methods:

  • Review of existing literature on gastroduodenal Crohn's disease.
  • Analysis of prevalence, diagnostic methods, and treatment strategies.

Main Results:

  • Clinically significant gastroduodenal Crohn's disease is infrequent.

Related Experiment Videos

  • Endoscopic and histological detection rates are higher than symptomatic presentation.
  • Standard medical therapies for distal CD are generally applicable, with specific formulation considerations for sulfasalazine and mesalazine.
  • Obstructive gastroduodenal symptoms necessitate aggressive treatment, including medical therapy, balloon dilation, or surgery.

    • Conclusions:

    • Gastroduodenal Crohn's disease is often subclinical but can present with obstructive symptoms.
    • Management decisions are guided by symptom severity and disease activity, with a tiered approach from medical therapy to interventional procedures.